Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent

NCT00894062 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Zotarolimus eluting stent (Endeavor resoulte - ZES resolute)
DEVICE: Everolimus eluting stent (Xience - EES)

Sponsor

Yonsei University

Collaborators

[object Object]